About Ind Swift Limited
Data last updated:
Ind Swift Limited was a public limited company based in Chandigarh, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 June 1986.
The company was registered with the Registrar of Companies (ROC), Chandigarh, under CIN L24230CH1986PLC006897. Its GSTIN is 04AAACI6100L1ZY (Chandigarh). The company held 32 GST registrations, of which 16 are active. Its shares are listed on BSE: 524652 and NSE: INDSWFTLTD.
The company had an authorised share capital of ₹40 Cr and a paid-up capital of ₹25.03 Cr. It was led by directors including Gopal Munjal (Managing Director) and Sanjeev Rai Mehta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 781 Industrial Area Phase II, Chandigarh, India – 160002.
As per the financials filed for FY 2024, the company reported a revenue of ₹560.24 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹14.23 Cr (net margin 2.5%) and EBITDA of ₹106.51 Cr (EBITDA margin 19%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.
The company had about 1,124 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Ind-Swift. As per MCA filings, the company had open charges of ₹818.22 Cr and satisfied charges of ₹6,337.79 Cr on record. Court records list 1,112 cases involving the company, including 508 filed by the company and 581 filed against it; 83 cases are pending. The company has 58 deals on record (57 market trades, 1 acquisition); the latest was in June 2025. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Malik Lifesciences Private Limited with revenue of ₹595.52 Cr.
The last known website on record is indswiftltd.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address781 Industrial Area Phase II, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ind Swift Limited
The main business activity of Ind Swift is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ind Swift Limited FY 2024 filings available
Ind Swift Limited reported revenue of ₹560.24 Cr (up 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ind Swift Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 33% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ind Swift Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹560.24 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹106.51 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14.23 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ind Swift Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ind Swift are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ind Swift Limited
Ind Swift Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Malik Lifesciences Private Limited | ₹595.52 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Panacea Biotec Limited | ₹584.97 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Delhi, India |
| Acme Formulation Private Limited | ₹577 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Himachal Pradesh, India |
| Bajaj Healthcare Limited Listed | ₹562.01 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Thane, Maharashtra, India |
| G S Pharmbutor Private Limited | ₹561.56 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Rudrapur, Uttarakhand, India |
| Ind Swift Limited this company | ₹560.24 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Chandigarh, India |
| Shalina Laboratories Private Limited | ₹551.12 Cr (FY 2023) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| German Remedies Pharmaceuticals Private Limited | ₹546.98 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Ahmedabad, Gujarat, India |
| Graviti Pharmaceuticals Private Limited | ₹543.75 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| Hydra Active Pharma Sciences Private Limited | ₹542.62 Cr (FY 2021) | •••• | •••• | 165.0% | •••• | Bangalore, Karnataka, India |
| Kusum Healthcare Private Limited | ₹537.89 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Ind Swift by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ind Swift Limited
Ind Swift Limited is audited by Jain & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Jain & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ind Swift Limited
Ind Swift has 12 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishav Mehta | Additional Director | 23 Mar 2010 | 16 Years 6 Months | As last reported |
| Himanshu Jain | Director | 31 Jul 2003 | 23 Years 2 Months | As last reported |
| Navrattan Munjal Also directs: Ind Swift Laboratories Limited, MJM Remedies Private Limited, Essix Biosciences Limited and 2 more | Director | 11 Dec 2006 | 19 Years 9 Months | As last reported |
| Jagvir Singh Ahluwalia Also directs: MSD Labs Private Limited | Director | 29 Aug 2017 | 9 Years 1 Months | As last reported |
| Sanjeev Rai Mehta | Whole-Time Director | 30 Nov 2006 | 19 Years 10 Months | As last reported |
| Vikrant Rai Mehta | Whole-Time Director | 30 Sep 1993 | 33 Years 0 Months | As last reported |
Ownership and Shareholding of Ind Swift Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ind Swift Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Oct 2020 | Axis Bank Limited | ₹1.1 Cr | Satisfied |
| 07 Oct 2020 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
| 30 Sep 2019 | Axis Bank Limited | ₹10.7 Cr | Satisfied |
| 28 Mar 2013 | Others | ₹1,002.87 Cr | Satisfied |
| 29 Jan 2013 | Others | ₹976.86 Cr | Satisfied |
Total charge records: 78 View all charges
Deals & Funding of Ind Swift Limited
Ind Swift Limited has 58 deals on record (57 market trades, 1 acquisition); the latest was in June 2025.
Deals on record (5 of 58)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Acquisition | ₹60 Cr | Buyer: Ang Lifesciences India Limited Seller: Ind Swift Limited |
| Aug 2021 | Market trade | ₹29.8 Lakh | Seller: Altruistic Trading Private Limited |
| Nov 2006 | Market trade | ₹2.28 Cr | Buyer: an individual Seller: Samradha Finstock Private Limited , an individual |
| Jun 2006 | Market trade | ₹74.6 Lakh | Buyer: Goldman Sachs And Company Seller: Speedway Trading Private Limited |
| May 2006 | Market trade | ₹1 Cr | Buyer: Simcorp Fund Limited |
Full deal history
All 58 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Ind Swift Limited
Ind Swift Limited has 1,112 court cases on record: 508 filed by Ind Swift, 581 filed against it, 23 where it is another party. 83 cases are pending and 1,029 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 933 | 496 | 58 |
| High courts | 171 | 81 | 25 |
| Supreme Court | 8 | 4 | 0 |
Cases on record (5 of 1,112)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Execution petition | Filed against the company by Daga Poly Laminators Private Limited | Pending |
| District court, Chandigarh | Court case (CS CJ) | Filed against the company by DLG Food Services Private Limited | Pending |
| District court, Solan, Himachal Pradesh | Civil miscellaneous application | Filed by the company against Elder Laboratories Limited | Pending |
| District court, Solan, Himachal Pradesh | Civil suit | Filed by the company against Elder Laboratories Limited | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by Sanchem Sophin Private Limited | Disposed |
Full case history
All 1,112 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Ind Swift Limited
Ind Swift operates one associated brand: Ind-Swift. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products, APIs, and herbal formulations are manufactured. | indswiftltd.com |
Employees and EPFO Compliance at Ind Swift Limited
Ind Swift Limited has a workforce of 1,124 employees as of Oct 08, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Ind Swift Limited
Ind Swift has one previous CIN (Corporate Identification Number): U24230CH1986PLC006897. The current CIN is L24230CH1986PLC006897, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230CH1986PLC006897 | Current |
| U24230CH1986PLC006897 | Previous |
News related to Ind Swift Limited
Recent Activity on Ind Swift Limited
Ind Swift Limited has 48 board changes on record since 1986: 30 appointments and 18 cessations. The latest: Prabhat Khurana was appointed as Director on 01 Apr 2024.
235 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ind Swift Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ind Swift Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ind Swift Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ind Swift Limited
Ind Swift has 32 GST registrations: 16 active and 16 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAACI6100L1ZY | Chandigarh | Active | 01 Jul 2017 |
| 04AAACI6100L2ZX | Chandigarh | Active | 10 Jul 2017 |
| 04AAACI6100L4ZV | Chandigarh | Active | 22 Feb 2019 |
| 02AAACI6100L2Z1 | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ind Swift Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ind Swift Limited
Ind Swift has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Ind Swift was a public limited company based in Chandigarh, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 06 June 1986 and is registered under CIN L24230CH1986PLC006897. Listed on BSE: 524652 and NSE: INDSWFTLTD. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Ind Swift was incorporated on 06 June 1986. It is registered with the Registrar of Companies, Chandigarh.
Ind Swift had 12 directors:
- Gopal Munjal - Managing Director
- Sanjeev Rai Mehta - Whole-Time Director
- Vikrant Rai Mehta - Whole-Time Director
- Rishav Mehta - Additional Director
- Himanshu Jain - Director
- Navrattan Munjal - Director
- Jagvir Singh Ahluwalia - Director
- Subhash Chander Galhotra - Director
- Anoop Michra - Director
- Bhupinder Singh - Director
- Subodh Gupta - Director
- Prabhat Khurana - Director
The CIN (Corporate Identification Number) of Ind Swift is L24230CH1986PLC006897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Ind Swift is listed on both BSE (code: 524652) and NSE (symbol: INDSWFTLTD).
The registered office of Ind Swift is at 781 Industrial Area Phase II, Chandigarh, India – 160002.
Ind Swift can be reached through the website indswiftltd.com. Its registered office is in Chandigarh, India.
Ind Swift reported revenue of ₹560.24 Cr for FY 2024 (up 33% YoY).
Ind Swift has an authorised share capital of ₹40 Cr and a paid-up capital of ₹25.03 Cr.
Ind Swift reported a net profit of ₹14.23 Cr (net margin 2.5%) and EBITDA of ₹106.51 Cr (EBITDA margin 19%) for FY 2024, as per its filed financial statements.